Patterns of new glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes during 2014–2019 from a US database: prescriber and patient characteristics

Ildiko Lingvay; Vanita R. Aroda; Julie Broe Honoré; Anne S. Ersbøll; Lise Lotte Nystrup Husemoen; Anders Boeck Jensen; Kasper Sommer Matthiessen; Mikhail Naum Kosiborod

doi:10.1111/1753-0407.13363

Patterns of new glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes during 2014–2019 from a US database: prescriber and patient characteristics

Ildiko Lingvay, Vanita R. Aroda, Julie Broe Honoré, Anne S. Ersbøll, Lise Lotte Nystrup Husemoen, Anders Boeck Jensen, Kasper Sommer Matthiessen, Mikhail Naum Kosiborod

Research output: Contribution to journal › Letter › peer-review

2 Scopus citations

Original language	English
Pages (from-to)	190-195
Number of pages	6
Journal	Journal of Diabetes
Volume	15
Issue number	2
DOIs	https://doi.org/10.1111/1753-0407.13363
State	Published - Feb 2023
Externally published	Yes

Keywords

ASCVD
CVOT
GLP-1 RA
cardiovascular
type 2 diabetes

Access to Document

10.1111/1753-0407.13363

Cite this

Lingvay, I., Aroda, V. R., Honoré, J. B., Ersbøll, A. S., Nystrup Husemoen, L. L., Jensen, A. B., Sommer Matthiessen, K., & Kosiborod, M. N. (2023). Patterns of new glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes during 2014–2019 from a US database: prescriber and patient characteristics. Journal of Diabetes, 15(2), 190-195. https://doi.org/10.1111/1753-0407.13363

@article{1e9532345d15425cbb60abb36bd7d8f8,

title = "Patterns of new glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes during 2014–2019 from a US database: prescriber and patient characteristics",

keywords = "ASCVD, CVOT, GLP-1 RA, cardiovascular, type 2 diabetes",

author = "Ildiko Lingvay and Aroda, {Vanita R.} and Honor{\'e}, {Julie Broe} and Ersb{\o}ll, {Anne S.} and {Nystrup Husemoen}, {Lise Lotte} and Jensen, {Anders Boeck} and {Sommer Matthiessen}, Kasper and Kosiborod, {Mikhail Naum}",

note = "Funding Information: Medical writing and editorial support were provided by Alice Garrett, Malgorzata Urbacz, and Izabel James, of Ashfield MedComms, an Inizio company, funded by Novo Nordisk A/S. Further Novo Nordisk staff contributed to this work: Shahzleen Rajan participated in planning and interpretation; Akasha Strub assisted with gathering data; Mads Reinholdt S{\o}rensen caried out review of the code for data gathering and analysis; and Dina Graae Kristensen and Rishibha Sachdev participated in planning and coordination of the work. This study was supported by Novo Nordisk A/S. ",

year = "2023",

month = feb,

doi = "10.1111/1753-0407.13363",

language = "English",

volume = "15",

pages = "190--195",

journal = "Journal of Diabetes",

issn = "1753-0393",

publisher = "Wiley-Blackwell",

number = "2",

}

Lingvay, I, Aroda, VR, Honoré, JB, Ersbøll, AS, Nystrup Husemoen, LL, Jensen, AB, Sommer Matthiessen, K & Kosiborod, MN 2023, 'Patterns of new glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes during 2014–2019 from a US database: prescriber and patient characteristics', Journal of Diabetes, vol. 15, no. 2, pp. 190-195. https://doi.org/10.1111/1753-0407.13363

TY - JOUR

T1 - Patterns of new glucagon-like peptide-1 receptor agonist use in patients with type 2 diabetes during 2014–2019 from a US database

T2 - prescriber and patient characteristics

AU - Lingvay, Ildiko

AU - Aroda, Vanita R.

AU - Honoré, Julie Broe

AU - Ersbøll, Anne S.

AU - Nystrup Husemoen, Lise Lotte

AU - Jensen, Anders Boeck

AU - Sommer Matthiessen, Kasper

AU - Kosiborod, Mikhail Naum

N1 - Funding Information: Medical writing and editorial support were provided by Alice Garrett, Malgorzata Urbacz, and Izabel James, of Ashfield MedComms, an Inizio company, funded by Novo Nordisk A/S. Further Novo Nordisk staff contributed to this work: Shahzleen Rajan participated in planning and interpretation; Akasha Strub assisted with gathering data; Mads Reinholdt Sørensen caried out review of the code for data gathering and analysis; and Dina Graae Kristensen and Rishibha Sachdev participated in planning and coordination of the work. This study was supported by Novo Nordisk A/S.

PY - 2023/2

Y1 - 2023/2

KW - ASCVD

KW - CVOT

KW - GLP-1 RA

KW - cardiovascular

KW - type 2 diabetes

UR - http://www.scopus.com/inward/record.url?scp=85148257168&partnerID=8YFLogxK

U2 - 10.1111/1753-0407.13363

DO - 10.1111/1753-0407.13363

M3 - Letter

C2 - 36796312

AN - SCOPUS:85148257168

SN - 1753-0393

VL - 15

SP - 190

EP - 195

JO - Journal of Diabetes

JF - Journal of Diabetes

IS - 2

ER -